| 0 |
SPINAL MENINGIOMA BENIGN |
2 |
0.0377 |
| 1 |
FEMALE SEX HORMONE LEVEL ABNORMAL |
1 |
0.0227 |
| 2 |
DECIDUAL CAST |
1 |
0.0200 |
| 3 |
ORBITAL SWELLING |
1 |
0.0172 |
| 4 |
INTRACARDIAC PRESSURE INCREASED |
1 |
0.0114 |
| 5 |
HABITUAL ABORTION |
1 |
0.0088 |
| 6 |
UTERINE ADHESIONS |
1 |
0.0078 |
| 7 |
SACROILIAC JOINT DYSFUNCTION |
1 |
0.0075 |
| 8 |
NOCTURNAL FEAR |
1 |
0.0072 |
| 9 |
PINEAL GLAND CYST |
1 |
0.0071 |
| 10 |
TANNING |
1 |
0.0068 |
| 11 |
BLOOD INSULIN DECREASED |
1 |
0.0065 |
| 12 |
BLOOD COPPER INCREASED |
1 |
0.0056 |
| 13 |
PREMENSTRUAL DYSPHORIC DISORDER |
1 |
0.0049 |
| 14 |
HERNIA HIATUS REPAIR |
1 |
0.0049 |
| 15 |
HAEMORRHOID OPERATION |
2 |
0.0045 |
| 16 |
ADENOTONSILLECTOMY |
1 |
0.0040 |
| 17 |
LAPAROSCOPY |
1 |
0.0038 |
| 18 |
GALLBLADDER OBSTRUCTION |
1 |
0.0038 |
| 19 |
SUDDEN VISUAL LOSS |
1 |
0.0036 |
| 20 |
CENTRAL SLEEP APNOEA SYNDROME |
1 |
0.0031 |
| 21 |
ILEECTOMY |
1 |
0.0030 |
| 22 |
PRODUCT SUBSTITUTION |
1 |
0.0025 |
| 23 |
FIBROADENOMA OF BREAST |
1 |
0.0022 |
| 24 |
PERINATAL DEPRESSION |
1 |
0.0022 |
| 25 |
HEPATIC ADENOMA |
1 |
0.0019 |
| 26 |
ASPARTATE AMINOTRANSFERASE DECREASED |
1 |
0.0019 |
| 27 |
ENDOMETRIAL THICKENING |
1 |
0.0018 |
| 28 |
TONSILLAR DISORDER |
2 |
0.0018 |
| 29 |
ALLODYNIA |
2 |
0.0017 |
| 30 |
CORTISOL INCREASED |
1 |
0.0016 |
| 31 |
MAGNETIC RESONANCE IMAGING HEAD ABNORMAL |
1 |
0.0015 |
| 32 |
SARS-COV-2 TEST NEGATIVE |
1 |
0.0015 |
| 33 |
CENTRAL NERVOUS SYSTEM LYMPHOMA |
2 |
0.0015 |
| 34 |
INGROWN HAIR |
1 |
0.0014 |
| 35 |
OPHTHALMIC MIGRAINE |
1 |
0.0014 |
| 36 |
PARASOMNIA |
1 |
0.0014 |
| 37 |
ALANINE AMINOTRANSFERASE DECREASED |
1 |
0.0014 |
| 38 |
SYMPTOM MASKED |
1 |
0.0014 |
| 39 |
WITHDRAWAL BLEED |
1 |
0.0014 |
| 40 |
VITAMIN B COMPLEX DEFICIENCY |
1 |
0.0013 |
| 41 |
SYSTEMIC LUPUS ERYTHEMATOSUS RASH |
1 |
0.0013 |
| 42 |
INTERMENSTRUAL BLEEDING |
7 |
0.0013 |
| 43 |
COLON CANCER METASTATIC |
2 |
0.0012 |
| 44 |
ALTERED VISUAL DEPTH PERCEPTION |
1 |
0.0012 |
| 45 |
CEREBRAL VENOUS THROMBOSIS |
2 |
0.0011 |
| 46 |
TUMOUR HAEMORRHAGE |
3 |
0.0011 |
| 47 |
TELANGIECTASIA |
1 |
0.0010 |
| 48 |
HYPERVIGILANCE |
1 |
0.0010 |
| 49 |
HAEMANGIOMA OF LIVER |
1 |
0.0010 |
| 50 |
BRAIN STEM INFARCTION |
1 |
0.0010 |
| 51 |
GASTRIC CANCER STAGE IV |
2 |
0.0009 |
| 52 |
RIGHT VENTRICULAR DYSFUNCTION |
1 |
0.0009 |
| 53 |
ADMINISTRATION SITE PAIN |
1 |
0.0009 |
| 54 |
POLYMENORRHOEA |
3 |
0.0009 |
| 55 |
INFUSION SITE INFECTION |
2 |
0.0009 |
| 56 |
DYSFUNCTIONAL UTERINE BLEEDING |
1 |
0.0008 |
| 57 |
XEROSIS |
1 |
0.0008 |
| 58 |
INFUSION SITE IRRITATION |
1 |
0.0008 |
| 59 |
GASTROENTERITIS NOROVIRUS |
1 |
0.0008 |
| 60 |
POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME |
1 |
0.0007 |
| 61 |
CARBON DIOXIDE INCREASED |
1 |
0.0007 |
| 62 |
ELECTRIC SHOCK SENSATION |
2 |
0.0007 |
| 63 |
CATAPLEXY |
1 |
0.0007 |
| 64 |
OSTEOMALACIA |
1 |
0.0006 |
| 65 |
POLYCYSTIC OVARIES |
1 |
0.0006 |
| 66 |
ONYCHOLYSIS |
1 |
0.0006 |
| 67 |
RESPIRATORY RATE DECREASED |
2 |
0.0006 |
| 68 |
INFUSION SITE PRURITUS |
2 |
0.0006 |
| 69 |
INAPPROPRIATE AFFECT |
1 |
0.0006 |
| 70 |
NIGHT BLINDNESS |
1 |
0.0006 |
| 71 |
OROPHARYNGEAL BLISTERING |
1 |
0.0006 |
| 72 |
BRADYARRHYTHMIA |
1 |
0.0006 |
| 73 |
SEBORRHOEIC DERMATITIS |
1 |
0.0006 |
| 74 |
PRODUCT COUNTERFEIT |
1 |
0.0006 |
| 75 |
HYPOPNOEA |
2 |
0.0006 |
| 76 |
FOOD INTERACTION |
1 |
0.0006 |
| 77 |
PANCREATIC FAILURE |
1 |
0.0006 |
| 78 |
DYSMENORRHOEA |
7 |
0.0005 |
| 79 |
METRORRHAGIA |
9 |
0.0005 |
| 80 |
NASAL SEPTUM DEVIATION |
1 |
0.0005 |
| 81 |
LIBIDO INCREASED |
1 |
0.0005 |
| 82 |
REBOUND ECZEMA |
1 |
0.0005 |
| 83 |
IMPULSE-CONTROL DISORDER |
1 |
0.0005 |
| 84 |
ATTENTION DEFICIT HYPERACTIVITY DISORDER |
2 |
0.0005 |
| 85 |
SLEEP DEFICIT |
1 |
0.0005 |
| 86 |
DEREALISATION |
1 |
0.0005 |
| 87 |
REACTION TO DRUG EXCIPIENTS |
1 |
0.0005 |
| 88 |
CERVICAL DYSPLASIA |
1 |
0.0005 |
| 89 |
ABDOMINAL ABSCESS |
2 |
0.0005 |
| 90 |
TEMPERATURE REGULATION DISORDER |
1 |
0.0004 |
| 91 |
APPLICATION SITE URTICARIA |
1 |
0.0004 |
| 92 |
IDIOPATHIC INTRACRANIAL HYPERTENSION |
1 |
0.0004 |
| 93 |
BRAIN OPERATION |
1 |
0.0004 |
| 94 |
SINUS PAIN |
1 |
0.0004 |
| 95 |
FOOT OPERATION |
2 |
0.0004 |
| 96 |
EYELID IRRITATION |
1 |
0.0004 |
| 97 |
SEDATION COMPLICATION |
1 |
0.0004 |
| 98 |
ILEOSTOMY |
1 |
0.0004 |
| 99 |
LACTOSE INTOLERANCE |
1 |
0.0004 |
| 100 |
PREGNANCY ON ORAL CONTRACEPTIVE |
1 |
0.0004 |
| 101 |
BREAST SWELLING |
1 |
0.0004 |
| 102 |
BRUXISM |
2 |
0.0004 |
| 103 |
MOOD ALTERED |
10 |
0.0004 |
| 104 |
PRODUCT SUBSTITUTION ISSUE |
21 |
0.0004 |
| 105 |
HYPOMENORRHOEA |
1 |
0.0004 |
| 106 |
TRICHORRHEXIS |
1 |
0.0004 |
| 107 |
MENSTRUATION IRREGULAR |
9 |
0.0003 |
| 108 |
HEAVY MENSTRUAL BLEEDING |
3 |
0.0003 |
| 109 |
EMBOLISM VENOUS |
1 |
0.0003 |
| 110 |
INFUSION SITE SWELLING |
2 |
0.0003 |
| 111 |
BLEPHAROSPASM |
2 |
0.0003 |
| 112 |
VAGINAL DISCHARGE |
3 |
0.0003 |
| 113 |
REPRODUCTIVE COMPLICATION ASSOCIATED WITH DEVICE |
1 |
0.0003 |
| 114 |
PRODUCT SUPPLY ISSUE |
2 |
0.0003 |
| 115 |
HYPOMANIA |
1 |
0.0003 |
| 116 |
FEELING DRUNK |
2 |
0.0003 |
| 117 |
NEURODERMATITIS |
1 |
0.0003 |
| 118 |
BREAST TENDERNESS |
2 |
0.0003 |
| 119 |
SNORING |
1 |
0.0003 |
| 120 |
TENDON PAIN |
2 |
0.0003 |
| 121 |
SLEEP APNOEA SYNDROME |
5 |
0.0003 |
| 122 |
THYROID MASS |
1 |
0.0003 |
| 123 |
THERAPEUTIC PRODUCT EFFECT VARIABLE |
1 |
0.0003 |
| 124 |
EPIGASTRIC DISCOMFORT |
1 |
0.0003 |
| 125 |
PRODUCT ADMINISTRATION INTERRUPTED |
2 |
0.0003 |
| 126 |
AFFECTIVE DISORDER |
2 |
0.0003 |
| 127 |
HYPERPHAGIA |
1 |
0.0003 |
| 128 |
FRUSTRATION TOLERANCE DECREASED |
2 |
0.0002 |
| 129 |
GOITRE |
1 |
0.0002 |
| 130 |
GENERALISED TONIC-CLONIC SEIZURE |
4 |
0.0002 |
| 131 |
PURULENT DISCHARGE |
1 |
0.0002 |
| 132 |
SHOULDER OPERATION |
1 |
0.0002 |
| 133 |
PSEUDOMONAS INFECTION |
2 |
0.0002 |
| 134 |
TEARFULNESS |
1 |
0.0002 |
| 135 |
CATHETERISATION CARDIAC |
1 |
0.0002 |
| 136 |
IRON DEFICIENCY |
1 |
0.0002 |
| 137 |
PELVIC PAIN |
4 |
0.0002 |
| 138 |
MOOD SWINGS |
7 |
0.0002 |
| 139 |
DYSPAREUNIA |
1 |
0.0002 |
| 140 |
ROSACEA |
1 |
0.0002 |
| 141 |
VAGINAL INFECTION |
1 |
0.0002 |
| 142 |
HORMONE LEVEL ABNORMAL |
1 |
0.0002 |
| 143 |
SKIN HAEMORRHAGE |
3 |
0.0002 |
| 144 |
GASTROINTESTINAL SOUNDS ABNORMAL |
1 |
0.0002 |
| 145 |
DYSPHORIA |
1 |
0.0002 |
| 146 |
BRAIN FOG |
3 |
0.0002 |
| 147 |
BREAST PAIN |
2 |
0.0002 |
| 148 |
AUTISM SPECTRUM DISORDER |
1 |
0.0002 |
| 149 |
CHOKING SENSATION |
1 |
0.0002 |
| 150 |
CYSTIC FIBROSIS |
1 |
0.0002 |
| 151 |
PERIORBITAL SWELLING |
1 |
0.0002 |
| 152 |
GENERALISED ERYTHEMA |
1 |
0.0002 |
| 153 |
MICTURITION URGENCY |
2 |
0.0002 |
| 154 |
SOCIAL AVOIDANT BEHAVIOUR |
1 |
0.0002 |
| 155 |
HYPERTRIGLYCERIDAEMIA |
1 |
0.0002 |
| 156 |
ENERGY INCREASED |
1 |
0.0002 |
| 157 |
GLUCOSE TOLERANCE IMPAIRED |
1 |
0.0002 |
| 158 |
SINUS HEADACHE |
1 |
0.0002 |
| 159 |
SYMPTOM RECURRENCE |
1 |
0.0002 |
| 160 |
DERMATITIS ACNEIFORM |
1 |
0.0002 |
| 161 |
PRE-EXISTING CONDITION IMPROVED |
1 |
0.0002 |
| 162 |
NASAL DRYNESS |
1 |
0.0002 |
| 163 |
INFUSION SITE PAIN |
2 |
0.0002 |
| 164 |
INCOHERENT |
1 |
0.0002 |
| 165 |
SKIN FISSURES |
3 |
0.0002 |
| 166 |
DERMATITIS ATOPIC |
8 |
0.0002 |
| 167 |
PRODUCT FORMULATION ISSUE |
1 |
0.0002 |
| 168 |
CORONAVIRUS INFECTION |
1 |
0.0002 |
| 169 |
RESPIRATION ABNORMAL |
1 |
0.0001 |
| 170 |
PAPULE |
1 |
0.0001 |
| 171 |
RETCHING |
3 |
0.0001 |
| 172 |
INTENTIONAL DOSE OMISSION |
4 |
0.0001 |
| 173 |
IMPAIRED QUALITY OF LIFE |
2 |
0.0001 |
| 174 |
LIQUID PRODUCT PHYSICAL ISSUE |
1 |
0.0001 |
| 175 |
INTENTIONAL UNDERDOSE |
1 |
0.0001 |
| 176 |
MAJOR DEPRESSION |
1 |
0.0001 |
| 177 |
MOUTH HAEMORRHAGE |
1 |
0.0001 |
| 178 |
SUNBURN |
1 |
0.0001 |
| 179 |
PAROSMIA |
1 |
0.0001 |
| 180 |
DISSOCIATION |
1 |
0.0001 |
| 181 |
INJECTION SITE RASH |
4 |
0.0001 |
| 182 |
APNOEA |
1 |
0.0001 |
| 183 |
MULTIPLE ALLERGIES |
1 |
0.0001 |
| 184 |
ELECTROCARDIOGRAM ABNORMAL |
1 |
0.0001 |
| 185 |
CYANOSIS |
2 |
0.0001 |
| 186 |
MIGRAINE |
12 |
0.0001 |
| 187 |
NIGHT SWEATS |
4 |
0.0001 |
| 188 |
DECUBITUS ULCER |
1 |
0.0001 |
| 189 |
POLYURIA |
1 |
0.0001 |
| 190 |
UPPER-AIRWAY COUGH SYNDROME |
1 |
0.0001 |
| 191 |
MENSTRUAL DISORDER |
1 |
0.0001 |
| 192 |
EMBOLISM |
1 |
0.0001 |
| 193 |
EYE PRURITUS |
4 |
0.0001 |
| 194 |
SENSATION OF FOREIGN BODY |
1 |
0.0001 |
| 195 |
SKIN PLAQUE |
1 |
0.0001 |
| 196 |
UTERINE PERFORATION |
1 |
0.0001 |
| 197 |
VITAMIN D DECREASED |
1 |
0.0001 |
| 198 |
IRRITABILITY |
7 |
0.0001 |
| 199 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
1 |
0.0001 |
| 200 |
ECZEMA |
6 |
0.0001 |
| 201 |
RASH MACULAR |
4 |
0.0001 |
| 202 |
AMENORRHOEA |
2 |
0.0001 |
| 203 |
EAR INFECTION |
3 |
0.0001 |
| 204 |
FOREIGN BODY IN REPRODUCTIVE TRACT |
1 |
0.0001 |
| 205 |
MYOSITIS |
1 |
0.0001 |
| 206 |
LIP DRY |
1 |
0.0001 |
| 207 |
CRYING |
4 |
0.0001 |
| 208 |
OPTIC NEURITIS |
1 |
0.0001 |
| 209 |
ABNORMAL DREAMS |
3 |
0.0001 |
| 210 |
PRODUCT DISTRIBUTION ISSUE |
1 |
0.0001 |
| 211 |
HEPATIC ENCEPHALOPATHY |
1 |
0.0001 |
| 212 |
ABORTION INDUCED |
1 |
0.0001 |
| 213 |
PAIN IN JAW |
3 |
0.0001 |
| 214 |
FEELING JITTERY |
2 |
0.0001 |
| 215 |
VITAMIN D DEFICIENCY |
1 |
0.0001 |
| 216 |
COELIAC DISEASE |
1 |
0.0001 |
| 217 |
MENORRHAGIA |
2 |
0.0001 |
| 218 |
BODY TEMPERATURE DECREASED |
1 |
0.0001 |
| 219 |
EMBEDDED DEVICE |
1 |
0.0001 |
| 220 |
DRY EYE |
5 |
0.0001 |
| 221 |
OVARIAN CYST |
1 |
0.0001 |
| 222 |
PRODUCT PREPARATION ERROR |
2 |
0.0001 |
| 223 |
VENTRICULAR EXTRASYSTOLES |
1 |
0.0001 |
| 224 |
EYE DISCHARGE |
1 |
0.0001 |
| 225 |
DERMATITIS |
2 |
0.0001 |
| 226 |
FOLLICULITIS |
1 |
0.0001 |
| 227 |
SKIN EXFOLIATION |
8 |
0.0001 |
| 228 |
HEAD INJURY |
3 |
0.0001 |
| 229 |
PULMONARY EMBOLISM |
9 |
0.0001 |
| 230 |
DECREASED ACTIVITY |
1 |
0.0001 |
| 231 |
PRURITUS GENERALISED |
2 |
0.0001 |
| 232 |
ACNE |
7 |
0.0001 |
| 233 |
MENSTRUATION DELAYED |
1 |
0.0001 |
| 234 |
PRODUCT PRESCRIBING ISSUE |
2 |
0.0001 |
| 235 |
PULMONARY THROMBOSIS |
1 |
0.0001 |
| 236 |
GASTROINTESTINAL PAIN |
1 |
0.0001 |
| 237 |
INJECTION SITE NODULE |
1 |
0.0001 |
| 238 |
FISTULA |
1 |
0.0001 |
| 239 |
ANGER |
3 |
0.0001 |
| 240 |
SCAB |
1 |
0.0001 |
| 241 |
SUICIDAL IDEATION |
8 |
0.0001 |
| 242 |
MUSCLE RIGIDITY |
1 |
0.0001 |
| 243 |
DEPRESSION |
19 |
0.0001 |
| 244 |
PRESYNCOPE |
2 |
0.0001 |
| 245 |
RESPIRATORY DEPRESSION |
1 |
0.0001 |
| 246 |
FEELING HOT |
5 |
0.0001 |
| 247 |
CARDIOMEGALY |
1 |
0.0001 |
| 248 |
SECRETION DISCHARGE |
1 |
0.0001 |
| 249 |
DYSPNOEA EXERTIONAL |
3 |
0.0001 |
| 250 |
BRAIN OEDEMA |
1 |
0.0001 |
| 251 |
BEDRIDDEN |
1 |
0.0001 |
| 252 |
IMMUNE SYSTEM DISORDER |
1 |
0.0001 |
| 253 |
ANKYLOSING SPONDYLITIS |
1 |
0.0001 |
| 254 |
ABNORMAL BEHAVIOUR |
3 |
0.0001 |
| 255 |
DEPRESSED MOOD |
4 |
0.0001 |
| 256 |
ADVERSE REACTION |
1 |
0.0001 |
| 257 |
DRY SKIN |
10 |
0.0001 |
| 258 |
HAIR TEXTURE ABNORMAL |
1 |
0.0001 |
| 259 |
QUALITY OF LIFE DECREASED |
1 |
0.0001 |
| 260 |
CENTRAL NERVOUS SYSTEM LESION |
1 |
0.0001 |
| 261 |
APPLICATION SITE RASH |
1 |
0.0001 |
| 262 |
APHONIA |
1 |
0.0001 |
| 263 |
SKIN REACTION |
1 |
0.0001 |
| 264 |
BLINDNESS UNILATERAL |
1 |
0.0001 |
| 265 |
EYE PAIN |
4 |
0.0001 |
| 266 |
HEART RATE INCREASED |
7 |
0.0001 |
| 267 |
FLATULENCE |
4 |
0.0001 |
| 268 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
5 |
0.0001 |
| 269 |
ANXIETY |
20 |
0.0001 |
| 270 |
VAGINAL HAEMORRHAGE |
3 |
0.0001 |
| 271 |
PULMONARY ARTERIAL HYPERTENSION |
1 |
0.0001 |
| 272 |
SINUSITIS |
7 |
0.0001 |
| 273 |
DRUG EFFECT LESS THAN EXPECTED |
1 |
0.0001 |
| 274 |
ABDOMINAL DISTENSION |
7 |
0.0001 |
| 275 |
THERAPEUTIC RESPONSE UNEXPECTED |
3 |
0.0001 |
| 276 |
HEPATIC FAILURE |
2 |
0.0001 |
| 277 |
EPILEPSY |
2 |
0.0001 |
| 278 |
HYPOKALAEMIA |
3 |
0.0001 |
| 279 |
MENINGIOMA |
1 |
0.0001 |
| 280 |
PNEUMOTHORAX |
1 |
0.0001 |
| 281 |
OBESITY |
1 |
0.0001 |
| 282 |
MULTIPLE SCLEROSIS |
3 |
0.0001 |
| 283 |
SCIATICA |
1 |
0.0001 |
| 284 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
3 |
0.0001 |
| 285 |
SENSORY DISTURBANCE |
1 |
0.0001 |
| 286 |
MUSCLE TIGHTNESS |
1 |
0.0001 |
| 287 |
PHOTOSENSITIVITY REACTION |
1 |
0.0001 |
| 288 |
HYPOAESTHESIA |
9 |
0.0001 |
| 289 |
SKIN DISORDER |
2 |
0.0001 |
| 290 |
HEMIPARESIS |
1 |
0.0001 |
| 291 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
1 |
0.0001 |
| 292 |
THERAPY CESSATION |
3 |
0.0001 |
| 293 |
SCAR |
1 |
0.0001 |
| 294 |
PARANOIA |
1 |
0.0001 |
| 295 |
PRODUCT DOSE OMISSION ISSUE |
17 |
0.0001 |
| 296 |
SLEEP DISORDER |
4 |
0.0001 |
| 297 |
HEAD DISCOMFORT |
1 |
0.0001 |
| 298 |
INSOMNIA |
15 |
0.0001 |
| 299 |
THIRST |
1 |
0.0001 |
| 300 |
MOBILITY DECREASED |
4 |
0.0001 |
| 301 |
COMPLICATION OF DEVICE REMOVAL |
1 |
0.0001 |
| 302 |
RESTLESS LEGS SYNDROME |
1 |
0.0001 |
| 303 |
PANIC ATTACK |
2 |
0.0001 |
| 304 |
TREATMENT NONCOMPLIANCE |
3 |
0.0001 |
| 305 |
DYSURIA |
2 |
0.0001 |
| 306 |
ANAPHYLACTIC REACTION |
3 |
0.0001 |
| 307 |
OROPHARYNGEAL PAIN |
5 |
0.0001 |
| 308 |
DYSGEUSIA |
4 |
0.0001 |
| 309 |
EYE SWELLING |
2 |
0.0001 |
| 310 |
HOT FLUSH |
4 |
0.0001 |
| 311 |
GASTRIC ULCER |
1 |
0.0001 |
| 312 |
HERPES ZOSTER |
3 |
0.0001 |
| 313 |
LETHARGY |
3 |
0.0001 |
| 314 |
EAR PAIN |
1 |
0.0001 |
| 315 |
SURGERY |
3 |
0.0001 |
| 316 |
ACTIVITIES OF DAILY LIVING IMPAIRED |
1 |
0.0001 |
| 317 |
COMPLICATION OF DEVICE INSERTION |
1 |
0.0001 |
| 318 |
FEELING ABNORMAL |
12 |
0.0001 |
| 319 |
PRODUCT PHYSICAL ISSUE |
1 |
0.0000 |
| 320 |
THERAPEUTIC RESPONSE DECREASED |
3 |
0.0000 |
| 321 |
HEADACHE |
31 |
0.0000 |
| 322 |
BODY TEMPERATURE INCREASED |
1 |
0.0000 |
| 323 |
CHEST DISCOMFORT |
5 |
0.0000 |
| 324 |
DRUG DOSE OMISSION |
8 |
0.0000 |
| 325 |
HAEMORRHAGE |
5 |
0.0000 |
| 326 |
MOUTH ULCERATION |
1 |
0.0000 |
| 327 |
HALLUCINATION, VISUAL |
1 |
0.0000 |
| 328 |
IMPAIRED WORK ABILITY |
1 |
0.0000 |
| 329 |
RHINORRHOEA |
3 |
0.0000 |
| 330 |
DEEP VEIN THROMBOSIS |
3 |
0.0000 |
| 331 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
1 |
0.0000 |
| 332 |
CONDITION AGGRAVATED |
14 |
0.0000 |
| 333 |
INTENTIONAL PRODUCT USE ISSUE |
4 |
0.0000 |
| 334 |
NAUSEA |
36 |
0.0000 |
| 335 |
COLITIS ULCERATIVE |
2 |
0.0000 |
| 336 |
VOMITING |
21 |
0.0000 |
| 337 |
SNEEZING |
1 |
0.0000 |
| 338 |
PANCREATITIS ACUTE |
1 |
0.0000 |
| 339 |
PRODUCT USE IN UNAPPROVED INDICATION |
11 |
0.0000 |
| 340 |
ERYTHEMA |
9 |
0.0000 |
| 341 |
SKIN IRRITATION |
2 |
0.0000 |
| 342 |
ABDOMINAL PAIN |
10 |
0.0000 |
| 343 |
BURNING SENSATION |
3 |
0.0000 |
| 344 |
OCULAR HYPERAEMIA |
2 |
0.0000 |
| 345 |
DISEASE RECURRENCE |
2 |
0.0000 |
| 346 |
PRODUCT PRESCRIBING ERROR |
1 |
0.0000 |
| 347 |
RASH ERYTHEMATOUS |
2 |
0.0000 |
| 348 |
MENTAL IMPAIRMENT |
1 |
0.0000 |
| 349 |
NEURALGIA |
1 |
0.0000 |
| 350 |
ABDOMINAL PAIN LOWER |
1 |
0.0000 |
| 351 |
PRODUCT COMPLAINT |
1 |
0.0000 |
| 352 |
FLUID RETENTION |
2 |
0.0000 |
| 353 |
INJECTION SITE SWELLING |
3 |
0.0000 |
| 354 |
PRURITUS |
15 |
0.0000 |
| 355 |
UNRESPONSIVE TO STIMULI |
1 |
0.0000 |
| 356 |
EXPOSURE VIA SKIN CONTACT |
1 |
0.0000 |
| 357 |
DIPLOPIA |
1 |
0.0000 |
| 358 |
MUSCLE SPASMS |
7 |
0.0000 |
| 359 |
PARAESTHESIA |
6 |
0.0000 |
| 360 |
DIZZINESS |
19 |
0.0000 |
| 361 |
NASOPHARYNGITIS |
7 |
0.0000 |
| 362 |
HYPERSENSITIVITY |
7 |
0.0000 |
| 363 |
INJECTION SITE HAEMORRHAGE |
3 |
0.0000 |
| 364 |
DIARRHOEA |
24 |
0.0000 |
| 365 |
PAIN OF SKIN |
1 |
0.0000 |
| 366 |
BLOOD BILIRUBIN INCREASED |
1 |
0.0000 |
| 367 |
DRY MOUTH |
3 |
0.0000 |
| 368 |
RASH |
16 |
0.0000 |
| 369 |
INFLUENZA LIKE ILLNESS |
3 |
0.0000 |
| 370 |
MEMORY IMPAIRMENT |
5 |
0.0000 |
| 371 |
DIVERTICULITIS |
1 |
0.0000 |
| 372 |
PROCEDURAL PAIN |
1 |
0.0000 |
| 373 |
FEELING COLD |
1 |
0.0000 |
| 374 |
NECK PAIN |
2 |
0.0000 |
| 375 |
WOUND |
1 |
0.0000 |
| 376 |
ABDOMINAL DISCOMFORT |
6 |
0.0000 |
| 377 |
NEEDLE ISSUE |
1 |
0.0000 |
| 378 |
PRODUCT STORAGE ERROR |
3 |
0.0000 |
| 379 |
DRUG WITHDRAWAL SYNDROME |
3 |
0.0000 |
| 380 |
PALPITATIONS |
4 |
0.0000 |
| 381 |
NASAL CONGESTION |
2 |
0.0000 |
| 382 |
GASTROINTESTINAL DISORDER |
3 |
0.0000 |
| 383 |
OEDEMA PERIPHERAL |
4 |
0.0000 |
| 384 |
VERTIGO |
2 |
0.0000 |
| 385 |
DISCOMFORT |
2 |
0.0000 |
| 386 |
EMOTIONAL DISORDER |
1 |
0.0000 |
| 387 |
EXPOSURE DURING PREGNANCY |
2 |
0.0000 |
| 388 |
FATIGUE |
25 |
0.0000 |
| 389 |
SWOLLEN TONGUE |
1 |
0.0000 |
| 390 |
DEVICE EXPULSION |
2 |
0.0000 |
| 391 |
PRODUCT DOSE OMISSION |
2 |
0.0000 |
| 392 |
CHOLELITHIASIS |
1 |
0.0000 |
| 393 |
IMPAIRED HEALING |
1 |
0.0000 |
| 394 |
THERAPEUTIC RESPONSE SHORTENED |
1 |
0.0000 |
| 395 |
EXPIRED PRODUCT ADMINISTERED |
1 |
0.0000 |
| 396 |
VIRAL INFECTION |
1 |
0.0000 |
| 397 |
DEHYDRATION |
4 |
0.0000 |
| 398 |
INJECTION SITE PRURITUS |
2 |
0.0000 |
| 399 |
URTICARIA |
5 |
0.0000 |
| 400 |
MALAISE |
13 |
0.0000 |
| 401 |
FLUSHING |
3 |
0.0000 |
| 402 |
MYALGIA |
5 |
0.0000 |
| 403 |
HEPATIC ENZYME INCREASED |
2 |
0.0000 |
| 404 |
URINARY TRACT INFECTION |
5 |
0.0000 |
| 405 |
ILLNESS |
3 |
0.0000 |
| 406 |
INJECTION SITE REACTION |
2 |
0.0000 |
| 407 |
NIGHTMARE |
1 |
0.0000 |
| 408 |
NEOPLASM PROGRESSION |
1 |
0.0000 |
| 409 |
HEART RATE DECREASED |
1 |
0.0000 |
| 410 |
DYSPNOEA |
16 |
0.0000 |
| 411 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
1 |
0.0000 |
| 412 |
PRODUCT ADHESION ISSUE |
1 |
0.0000 |
| 413 |
THERAPY INTERRUPTED |
2 |
0.0000 |
| 414 |
SKIN BURNING SENSATION |
2 |
0.0000 |
| 415 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
5 |
0.0000 |
| 416 |
DRUG EFFECT INCOMPLETE |
1 |
0.0000 |
| 417 |
CONSTIPATION |
6 |
0.0000 |
| 418 |
RESTLESSNESS |
1 |
0.0000 |
| 419 |
INJECTION SITE MASS |
1 |
0.0000 |
| 420 |
BRONCHITIS |
2 |
0.0000 |
| 421 |
CHEST PAIN |
5 |
0.0000 |
| 422 |
THROMBOCYTOPENIA |
3 |
0.0000 |
| 423 |
PRODUCT USE ISSUE |
5 |
0.0000 |
| 424 |
DYSARTHRIA |
1 |
0.0000 |
| 425 |
ASTHMA |
3 |
0.0000 |
| 426 |
ANAEMIA |
5 |
0.0000 |
| 427 |
SEIZURE |
3 |
0.0000 |
| 428 |
CHILLS |
3 |
0.0000 |
| 429 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
1 |
0.0000 |
| 430 |
DISORIENTATION |
1 |
0.0000 |
| 431 |
GASTROOESOPHAGEAL REFLUX DISEASE |
2 |
0.0000 |
| 432 |
EXTRA DOSE ADMINISTERED |
1 |
0.0000 |
| 433 |
DEVICE BREAKAGE |
1 |
0.0000 |
| 434 |
DYSKINESIA |
1 |
0.0000 |
| 435 |
ABDOMINAL PAIN UPPER |
5 |
0.0000 |
| 436 |
INJECTION SITE ERYTHEMA |
3 |
0.0000 |
| 437 |
WITHDRAWAL SYNDROME |
1 |
0.0000 |
| 438 |
HYPERTENSION |
5 |
0.0000 |
| 439 |
HYPERHIDROSIS |
3 |
0.0000 |
| 440 |
DEVICE DISLOCATION |
1 |
0.0000 |
| 441 |
MENTAL DISORDER |
1 |
0.0000 |
| 442 |
PSORIASIS |
3 |
0.0000 |
| 443 |
INTENTIONAL PRODUCT MISUSE |
2 |
0.0000 |
| 444 |
COVID-19 |
4 |
0.0000 |
| 445 |
WEIGHT INCREASED |
5 |
0.0000 |
| 446 |
DEVICE ISSUE |
2 |
0.0000 |
| 447 |
PRODUCT QUALITY ISSUE |
3 |
0.0000 |
| 448 |
LOWER RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 449 |
VISION BLURRED |
3 |
0.0000 |
| 450 |
TINNITUS |
1 |
0.0000 |
| 451 |
ARTHRALGIA |
9 |
0.0000 |
| 452 |
DECREASED APPETITE |
5 |
0.0000 |
| 453 |
BACK PAIN |
5 |
0.0000 |
| 454 |
BLOOD CHOLESTEROL INCREASED |
1 |
0.0000 |
| 455 |
COGNITIVE DISORDER |
1 |
0.0000 |
| 456 |
WRONG TECHNIQUE IN DEVICE USAGE PROCESS |
1 |
0.0000 |
| 457 |
SWELLING |
2 |
0.0000 |
| 458 |
CONTUSION |
2 |
0.0000 |
| 459 |
LUNG DISORDER |
1 |
0.0000 |
| 460 |
DYSPEPSIA |
2 |
0.0000 |
| 461 |
SYNCOPE |
2 |
0.0000 |
| 462 |
SOMNOLENCE |
4 |
0.0000 |
| 463 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
4 |
0.0000 |
| 464 |
OFF LABEL USE |
17 |
0.0000 |
| 465 |
INFLAMMATION |
1 |
0.0000 |
| 466 |
DRUG EFFECT DECREASED |
1 |
0.0000 |
| 467 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 468 |
INFLUENZA |
2 |
0.0000 |
| 469 |
COUGH |
5 |
0.0000 |
| 470 |
BLISTER |
1 |
0.0000 |
| 471 |
CONVULSION |
1 |
0.0000 |
| 472 |
EYE IRRITATION |
1 |
0.0000 |
| 473 |
EMOTIONAL DISTRESS |
2 |
0.0000 |
| 474 |
STOMATITIS |
1 |
0.0000 |
| 475 |
ILL-DEFINED DISORDER |
1 |
0.0000 |
| 476 |
INJECTION SITE PAIN |
5 |
0.0000 |
| 477 |
VISUAL IMPAIRMENT |
2 |
0.0000 |
| 478 |
AMNESIA |
1 |
0.0000 |
| 479 |
SWELLING FACE |
1 |
0.0000 |
| 480 |
ALOPECIA |
3 |
0.0000 |
| 481 |
INFUSION RELATED REACTION |
1 |
0.0000 |
| 482 |
BLOOD PRESSURE DECREASED |
1 |
0.0000 |
| 483 |
MULTIPLE SCLEROSIS RELAPSE |
1 |
0.0000 |
| 484 |
WEIGHT DECREASED |
4 |
0.0000 |
| 485 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
1 |
0.0000 |
| 486 |
DRUG INEFFECTIVE |
18 |
0.0000 |
| 487 |
PAIN IN EXTREMITY |
4 |
0.0000 |
| 488 |
EPISTAXIS |
1 |
0.0000 |
| 489 |
UNEVALUABLE EVENT |
1 |
0.0000 |
| 490 |
INCORRECT DOSE ADMINISTERED |
3 |
0.0000 |
| 491 |
DRUG INTERACTION |
2 |
0.0000 |
| 492 |
INJECTION SITE BRUISING |
1 |
0.0000 |
| 493 |
THROMBOSIS |
1 |
0.0000 |
| 494 |
CONFUSIONAL STATE |
2 |
0.0000 |
| 495 |
PNEUMONIA |
4 |
0.0000 |
| 496 |
FOETAL EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 497 |
TREATMENT FAILURE |
1 |
0.0000 |
| 498 |
FALL |
4 |
0.0000 |
| 499 |
MUSCULOSKELETAL STIFFNESS |
1 |
0.0000 |
| 500 |
PAIN |
7 |
0.0000 |
| 501 |
TACHYCARDIA |
1 |
0.0000 |
| 502 |
MATERNAL EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 503 |
ADVERSE EVENT |
1 |
0.0000 |
| 504 |
BREAST CANCER |
1 |
0.0000 |
| 505 |
NEUROPATHY PERIPHERAL |
1 |
0.0000 |
| 506 |
GAIT DISTURBANCE |
2 |
0.0000 |
| 507 |
MALIGNANT NEOPLASM PROGRESSION |
1 |
0.0000 |
| 508 |
ACCIDENTAL EXPOSURE TO PRODUCT |
1 |
0.0000 |
| 509 |
LOSS OF CONSCIOUSNESS |
1 |
0.0000 |
| 510 |
INFECTION |
1 |
0.0000 |
| 511 |
HOSPITALISATION |
1 |
0.0000 |
| 512 |
TREMOR |
1 |
0.0000 |
| 513 |
PYREXIA |
2 |
0.0000 |
| 514 |
BLOOD GLUCOSE INCREASED |
1 |
0.0000 |
| 515 |
OVERDOSE |
1 |
0.0000 |
| 516 |
ASTHENIA |
1 |
0.0000 |
| 517 |
DEATH |
1 |
0.0000 |